German Camejo
Stockholm, AB 14186, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Vasculoprotective properties of plasma lipoproteins from brown bears (Ursus arctos).
Journal: Journal of lipid research
Published: March 10, 2020
Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients.
Journal: Journal of the American Heart Association
Published: December 19, 2018
Postprandial Hypertriglyceridemia Is Associated with the Variant 54 Threonine FABP2 Gene.
Journal: Journal of cardiovascular development and disease
Published: August 26, 2018
ApoB-100 Lipoprotein Complex Formation with Intima Proteoglycans as a Cause of Atherosclerosis and Its Possible Ex Vivo Evaluation as a Disease Biomarker.
Journal: Journal of cardiovascular development and disease
Published: June 14, 2018
Phase 2 clinical trials with K-877 (pemafibrate): A promising selective PPAR-α modulator for treatment of combined dyslipidemia.
Journal: Atherosclerosis
Published: April 12, 2017
Fat Intolerance in Apparently Healthy Individuals with Normal Fasting Lipoproteins Is Associated with Markers of Cardiovascular Risk.
Journal: The journal of applied laboratory medicine
Published: July 05, 2016
Selective PPAR modulators (SPPARs) may fill the need for treatment of the atherogenic dyslipidemia of insulin resistance and type 2 diabetes: Can they reduce the associated cardiac risk?
Journal: Atherosclerosis
Published: March 17, 2016
Macrophages, extracellular matrix, and lipoproteins in arterial cholesterol balance.
Journal: Journal of lipid research
Published: November 21, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026